0.00Open3.75Pre Close0 Volume4 Open Interest140.00Strike Price0.00Turnover46.63%IV3.09%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry3.75Extrinsic Value100Contract SizeAmericanOptions Type-0.4958Delta0.0437Gamma37.49Leverage Ratio-0.2549Theta-0.0131Rho-18.59Eff Leverage0.0782Vega
ESCO Technologies Stock Discussion
In reaction to earnings/guidance:
• $Planet Labs PBC (PL.US)$ +11.3%, $Core & Main (CNM.US)$ +6.1%, $Regal Rexnord (RRX.US)$ +2% (reaffirms outlook), $Oracle (ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics (AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos (AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals (CPRX.US)$ +7.7...
No comment yet